Molecular updating of β-thalassemia mutations in the upper Egyptian population

Hemoglobin

Volumn 34, Issue 6, 2010, Pages 538-547

  Jiffri, Essam H ^a   Bogari, Neda ^b   Zidan, Khaled H ^c   Teama, Salwa ^d   Elhawary, Nasser A ^b,d  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^b UMM AL QURA UNIVERSITY   (Saudi Arabia)

^c ASSIUT UNIVERSITY   (Egypt)

^d AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

Thalassemia ( thal); Genetic drift; Mutation spectrum; Upper Egyptians

Indexed keywords

ADOLESCENT; ARTICLE; BETA THALASSEMIA; BETA THALASSEMIA MAJOR; CHILD; CODON; DNA SEQUENCE; EGYPT; FEMALE; FRAMESHIFT MUTATION; GENE MUTATION; GENETIC DRIFT; GENETIC IDENTIFICATION; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR GENETICS; MULTIPLEX AMPLIFICATION REFRACTORY MUTATION SYSTEM POLYMERASE CHAIN REACTION; MULTIPLEX POLYMERASE CHAIN REACTION; POPULATION GENETICS; PRESCHOOL CHILD; REVERSE DOT BLOT; SCHOOL CHILD;

ADOLESCENT; ALLELES; BETA-GLOBINS; BETA-THALASSEMIA; CHILD; CHILD, PRESCHOOL; DNA MUTATIONAL ANALYSIS; EGYPT; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MUTATION;

EID: 79952143119     PISSN: 03630269     EISSN: 1532432X     Source Type: Journal    
DOI: 10.3109/03630269.2010.526440     Document Type: Article

References (38)

1. Patrinos GP, Giardine B, Riemer C, et al. Improvements in the HbVar database of human hemoglobin variants and thalassemia mutations for population and sequence variation studies. Nucleic Acids Res. 2004;32(Database issue):D537-D541.
2. Weatherall DJ. Keynote address: The challenge of thalassemia for the developing countries. Ann NY Acad Sci. 2005;1054:11-17. (Pubitemid 43031005)
3. Hashem N. Thalassemia syndromes and other haemoglobinopathies prevalent among Egyptians. Preventable Aspects of Genetics Morbidity. Proceedings of the First International Conference held at Cairo, Egypt, March 30-April 4 1978. 1978;1:54-57.
4. Rady MS, Baffico M, Khalifa AS, et al. Identification of Mediterranean β-thalassemia mutations by reverse dot-blot in Italians and Egyptians. Hemoglobin. 1997;21(1):59-69. (Pubitemid 27057392)
5. el-Hashemite N, Petrou M, Khalifa AS, et al. Identification of novel Asian Indian and Japanese mutations causing β-thalassaemia in the Egyptian population. Hum Genet. 1997;99(2):271-274.
6. Shawky RM, Khalifa AS, Mokhtar GM, et al. Prenatal diagnosis of β-thalassemia via automated DHPLC analysis of fetal cells in maternal circulation, Egypt J Med Hum Genet. 2003;4(2):1-8.
7. Richards B, Skoletsky J, Shuber AP, et al. Multiplex PCR amplification from the CFTR gene using DNA prepared from buccal brushes/swabs. Hum Mol Genet. 1993;2(2):159-163.
8. Elhawary NA, Shawky RM, Hashem N. Frameshift deletion mechanisms in Egyptian Duchenne and Becker muscular dystrophy families. Mol Cells. 2004;18(2):141-149. (Pubitemid 40081206)
9. Fortina P, Dotti G, Conant R, et al. Detection of the most common mutations causing β-thalassemia in Mediterraneans using a multiplex amplification refractory mutation system (MARMS). PCR Methods Appl. 1992;2(2):163-166.
10. Ugozzoli LA, Lowery JD, Reyes AA, et al. Evaluation of the BeTha gene 1 kit for the qualitative detection of the eight most common Mediterranean beta-thalassemia mutations. Am J Hematol. 1998;59(3):214-222. (Pubitemid 28485502)
11. EDHS, Egypt Demographic Health Service (2008). http://www.measuredhs.com/ pubs/.
12. Weinreb AA. Characteristics of women in consanguineous marriages in Egypt, 1988-2000. Eur J Population/Revue européenne de Démographie. 2008;24(2):185-210.
13. Hussein FH. Endogamy in Egyptian Nubia. Biosoc Sci. 1971;3:351-357.
14. Novelletto A, Hafez M, Deidda G, et al. Molecular characterization of β-thalassemia mutations in Egypt. Hum Genet. 1990;85(3):272-274. (Pubitemid 20279547)
15. Hussein IR, Temtamy SA, el-Beshlawy A, et al. Molecular characterization of β-thalassemia in Egyptians. Hum Mutat. 1993;2(1):48-52.
16. Omar A, Abdel Karim E, Gendy WE, Marzouk I, Wagdy M. Molecular basis of β-thalassemia in Alexandria. Egypt J Immunol. 2005;12(1):15-24.
17. El-Beshlawy A, Kaddah N, Moustafa A, Mouktar G, Youssry I. Screening for β-thalassaemia carriers in Egypt: significance of the osmotic fragility test. East Mediterr Health J. 2007;13(4):780-786. (Pubitemid 47505598)
18. el-Gawhary S, El-Shafie S, Niazi M, Aziz M, El-Beshlawy A. Study of β-thalassemia mutations using the polymerase chain reaction-amplification refractory mutation system and direct DNA sequencing techniques in a group of Egyptian thalassemia patients. Hemoglobin. 2007;31(1):63-69.
19. Zahed L, Qatanani M, Nabulsi M, Taher A. β-Thalassemia mutations and haplotype analysis in Lebanon. Hemoglobin. 2000;24(4):269-276.
20. Patrinos GP, van Baal S, Petersen MB, Papadakis MN. Hellenic National Mutation database: a prototype database for mutations leading to inherited disorders in the Hellenic population. Hum Mutat. 2005;25(4):327-333. (Pubitemid 40524659)
21. Keser I, Sanlioglu AD, Manguoglu E, et al. Molecular analysis of β-thalassemia and sickle cell anemia in Antalya. Acta Haematol. 2004;111(4):205-210. (Pubitemid 38716195)
22. Zahed L. The Spectrum of β-thalassemia mutations in the Arab populations. J Biomed Biotechnol. 2001;1(3):129-132. (Pubitemid 46842819)
23. S haplotypes among Kuwaiti Arabs. Acta Haematol. 1994;92(4):176-181.
24. Amselem S, Nunes V, Vidaud M, et al. Determination of the spectrum of β-thalassemia genes in Spain by use of dot-blot analysis of amplified β-globin DNA. Am J Hum Genet. 1988;43(1):95-100.
25. Gomes MP, da Costa MG, Braga LB, et al. β-Thalassemia mutations in the Portuguese population. Hum Genet. 1988;78(1):13-15.
26. Bouhass R, Perrin P, Trabuchet G. The spectrum of β-thalassemia mutations in the Oran region of Algeria. Hemoglobin. 1994;18(3):211-219.
27. Chibani J, Vidaud M, Duquesnoy P, et al. The peculiar spectrum of β-thalassemia genes in Tunisia. Hum Genet. 1988;78(2):190-192. (Pubitemid 18069881)
28. Kyriacou K, Al Quobaili F, Pavlou E, Christopoulos G, Ioannou P, Kleanthous M. Molecular characterization of β-thalassemia in Syria. Hemoglobin. 2000;24(1):1-13.
29. Filon D, Faerman M, Smith P, Oppenheim A. Sequence analysis reveals a β-thalassaemia mutation in the DNA of skeletal remains from the archaeological site of Akhziv, Israel. Nat Genet. 1995;9(4):365-368.
30. Sadiq MF, Eigel A, Horst J. Spectrum of β-thalassemia in Jordan: identification of two novel mutations. Am J Hematol. 2001;68(1):16-22. (Pubitemid 32738715)
31. el-Hazmi MA, Warsy AS. Appraisal of sickle-cell and thalassaemia genes in Saudi Arabia. East Mediterr Health J. 1999;5(6):1147-1153.
32. Al-Ali AK, Al-Ateeq S, Imamwerdi BW, et al. Molecular bases of β-thalassemia in the Eastern Province of Saudi Arabia. J Biomed Biotechnol. 2005;2005(4):322-325. (Pubitemid 43129205)
33. Jassim N, Merghoub T, Pascaud O, et al. Molecular basis of β-thalassemia in Bahrain: an epicenter for a Middle East specific mutation. Ann NY Acad Sci. 1998;850:407-409. (Pubitemid 28369788)
34. Gamarra S, Garcia-Effron G, Monteserin C, et al. β-Thalassaemia major in a Spanish patient due to a compound heterozygosity for CD39C>T/-28A>C. Adv Hematol 2009;2009:476342.
35. Chehab FF, Der Kaloustian V, Khouri FP, Deeb SS, Kan YW. The molecular basis of β-thalassemia in Lebanon: application to prenatal diagnosis. Blood. 1987;69(4):1141-1145. (Pubitemid 17080937)
36. Bennani C, Bouhass R, Perrin-Pecontal P, et al. Anthropological approach to the heterogeneity of β-thalassemia mutations in northern Africa. Hum Biol. 1994;66(3):369-382. (Pubitemid 2079235)
37. Henderson S, Timbs A, McCarthy J, et al. Incidence of haemoglobinopathies in various populations - the impact of immigration. Clin Biochem. 2009;42(18):1745-1756.
38. Hasounah FH, Sejeny SA, Omer JA, Old JM, Oliver RW. Spectrum of β-thalassaemia mutations in the population of Saudi Arabia. Hum Hered. 1995;45(is4):231-234.